Fair Value Of Financial Instruments (Tables)

6 Months Ended

Mar. 31, 2021

Fair Value of Financial Instruments

Summary of assets and liabilities measured and recorded at fair value on Balance Sheet on a recurring basis

The following table presents assets and liabilities measured and recorded at fair value on our Condensed Consolidated Balance Sheets on a recurring basis (in thousands):

	March 31, 2021								September 30, 2020
	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Assets
Current derivative assets	$	—	$	2,177	$	—	$	2,177	$	—	$	1,398	$	—	$	1,398
Noncurrent derivative assets		—		229		—		229		—		222		—		222
Total assets measured at fair value	$	—	$	2,406	$	—	$	2,406	$	—	$	1,620	$	—	$	1,620
Liabilities
Current derivative liabilities		—		6,350		—		6,350		—		4,557		—		4,557
Noncurrent derivative liabilities		—		4,537		—		4,537		—		14,070		—		14,070
Contingent consideration to seller of H4 Global		—		—		—		—		—		—		1,148		1,148
Contingent consideration to seller of Deltenna		—		—		3,205		3,205		—		—		3,004		3,004
Contingent consideration to seller of Shield		—		—		6,811		6,811		—		—		5,566		5,566
Contingent consideration to seller of Delerrok		—		—		—		—		—		—		900		900
Total liabilities measured at fair value	$	—	$	10,887	$	10,016	$	20,903	$	—	$	18,627	$	10,618	$	29,245

Summary of change in fair value of contingent consideration liability

As of March 31, 2021, the following table summarizes the change in fair value of our Level 3 contingent consideration liabilities (in thousands):

	H4 Global		Deltenna		Shield		Nuvotronics		Delerrok		Total
Balance as of September 30, 2020	$	1,148	$	3,004	$	5,566	$	—	$	900	$	10,618
Cash paid to seller		(1,286)		—		—		—		—		(1,286)
Total remeasurement (gain) loss recognized in earnings		138		201		1,245		—		(900)		684
Balance as of March 31, 2021	$	—	$	3,205	$	6,811	$	—	$	—	$	10,016